Position in GRAL
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$11,219,728
-$7,015,221 QoQ
Shares Held
217,100
+1.9% QoQ
Ownership
0.486%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Carnegie Investment Counsel holds $32,106,957 across 5 Diagnostics & Research names.
All Filings in GRAL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,219,728 | 217,100 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $18,234,949 | 213,050 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $14,505,475 | 245,315 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $8,519,522 | 165,685 | Shares | Sole | 2025-07-31 | |
| No filing history on record for this holder in this stock. | ||||||